XML 117 R94.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Associates - Summary of Investments in Associates (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets $ 481,777 $ 178,786
Current liabilities 92,028 17,665
Revenue 77,948 39,895
Net loss (54,134) $ (7,572)
Investments Accounted for Using Equity Method    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 75,508  
Non-current assets 110,814  
Current liabilities 5,631  
Non-current liabilities 18,070  
Net loss (14,040)  
Investments Accounted for Using Equity Method | Agripharm Corp.    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 4,671  
Non-current assets 90,716  
Current liabilities 1,391  
Non-current liabilities 10,896  
Net loss (557)  
Investments Accounted for Using Equity Method | TerrAscend Corp    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 53,693  
Non-current assets 15,369  
Current liabilities 1,692  
Net loss (6,805)  
Investments Accounted for Using Equity Method | Radicle Medical Marijuana Inc    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 2,576  
Non-current assets 4,382  
Current liabilities 94  
Non-current liabilities 7,174  
Net loss (506)  
Investments Accounted for Using Equity Method | Canopy Health Innovations Inc.    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 12,160  
Non-current assets 123  
Current liabilities 364  
Net loss (3,949)  
Investments Accounted for Using Equity Method | Bedrocan Brasil S.A.    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 659  
Current liabilities 34  
Net loss (162)  
Investments Accounted for Using Equity Method | Entourage Phytolab S.A.    
Disclosure Of Significant Investments In Associates [Line Items]    
Current assets 1,749  
Non-current assets 224  
Current liabilities 2,056  
Net loss $ (2,061)